Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Observational

Parental Perception of Oral Health-Related Quality of Life in Sudanese Refugee vs. Egyptian Children

NCT07011381 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2025-06-10
Last updated
2025-08-26

Condition(s) studied

Dental CariesGingivitisOral HealthRefugee Health

Study summary

This cross-sectional analytical study aims to assess and compare parental perceptions of oral health-related quality of life (OHRQoL) among Sudanese refugee children and Egyptian children aged 6-12 years living in Egypt. The study will include 192 child-parent pairs (96 Sudanese refugees and 96 Egyptians). Data will be collected via a validated Arabic questionnaire adapted from the Child Oral Health Impact Profile (COHIP) and clinical oral health examinations using DMFT/dmft indices, Gingival Index, and Plaque Index. The study seeks to identify disparities in oral health, parental awareness, and access to dental care services, thereby informing future community-based interventions and public health policies targeting vulnerable populations such as refugee children.

Eligibility

Sex
ALL
Min age
6 Years
Max age
12 Years
Healthy volunteers
Accepted
Inclusion Criteria: Children aged 6-12 years Either Sudanese refugee or Egyptian national Resident in Cairo for at least 1 year Informed consent obtained from parent or legal guardian Exclusion Criteria: Systemic health conditions affecting oral health Ongoing orthodontic treatment Children with special health care needs or developmental disabilities

Primary outcome measure(s)

  • Mean Total Score on the Child Oral Health Impact Profile (COHIP) Questionnaire — Baseline (single clinical visit at enrollment)
    Measured using the validated Arabic version of the Child Oral Health Impact Profile (COHIP) questionnaire. Total score and domain-specific subscores (Oral Health, Functional Well-being, Emotional Well-being, School Environment, and Self-image) will be analyzed. Full name: Child Oral Health Impact Profile (COHIP), Arabic version Score range: 0 to 140 Higher scores = better oral health-related quality of life

Trial sites (1)

FacilityCityRegionStatus
Kafrelsheikh University, Faculty of Oral and Dental Medicine Kafr ash Shaykh Kafr Ash Shaikh/ Elhamrawy
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07011381 on ClinicalTrials.gov ↗ ← All trials in Egypt